<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY center_name="GEO" alias="GSE168642" accession="SRP310116">
    <IDENTIFIERS>
      <PRIMARY_ID>SRP310116</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject" label="primary">PRJNA713319</EXTERNAL_ID>
      <EXTERNAL_ID namespace="GEO">GSE168642</EXTERNAL_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>Transcriptome analysis of blood V?9 Vd2 gdT cells upon TCR and Notch signalling</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Transcriptome Analysis"/>
      <STUDY_ABSTRACT>We utilized RNA-seq to identify differential gene expression in V?9 Vd2 gdT cells isolated from human PBMCs upon TCR stimulation. We find that ~30% genes are commonly up- and down-regulated between different phosphoantigen treatments (p&lt;0.05). Inhibition of Notch signaling alongside TCR activation results in downregulation of many effector genes in V?9 Vd2 T cells. Overall design: PBMCs from healthy donors were subjected to MACS based gdT cell isolation. The isolated cells (~1 million each) were either untreated, treated with rIL2 only, or a combination of rIL2+IPP, rIL2+HDMAPP and rIL2+anti-CD3 for T cell activation. Notch signaling inhibitor treatment was done using GSI-X along with TCR activation. Three replicates were sequenced for all the 8 treatment samples.</STUDY_ABSTRACT>
      <CENTER_PROJECT_NAME>GSE168642</CENTER_PROJECT_NAME>
    </DESCRIPTOR>
    <STUDY_LINKS>
      <STUDY_LINK>
        <XREF_LINK>
          <DB>pubmed</DB>
          <ID>34526984</ID>
        </XREF_LINK>
      </STUDY_LINK>
    </STUDY_LINKS>
  </STUDY>
</STUDY_SET>
